Time impact on non-activated and kaolin-activated blood samples in thromboelastography
Jazyk angličtina Země Anglie, Velká Británie Médium electronic
Typ dokumentu klinické zkoušky, srovnávací studie, časopisecké články
PubMed
25927487
PubMed Central
PMC4404121
DOI
10.1186/s12871-015-0033-9
PII: 10.1186/s12871-015-0033-9
Knihovny.cz E-zdroje
- MeSH
- analýza rozptylu MeSH
- časové faktory MeSH
- citráty farmakologie MeSH
- kaolin farmakologie MeSH
- koagulancia farmakologie MeSH
- lidé MeSH
- odběr vzorku krve metody MeSH
- tromboelastografie metody MeSH
- zdraví dobrovolníci pro lékařské studie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- klinické zkoušky MeSH
- srovnávací studie MeSH
- Názvy látek
- citráty MeSH
- kaolin MeSH
- koagulancia MeSH
BACKGROUND: The correct methodology of thrombelastography might be influenced by elapsing time. In our study we investigated kaolin activated citrated samples together with non-activated citrated samples in relation to the elapsed times of 0, 15 and 30 minutes to compare both methods and to find out if there is an impact of time on results of thrombelastography. METHODS: Blood samples obtained from 10 healthy volunteers were analyzed after 0, 15 and 30 minutes from sampling with kaolin activation and without activation. Then the results were analysed and compared between the non-activated and the kaolin-activated method. RESULTS: All blood samples became more hypercoagulable with the time elapsing, both in non-activated and kaolin-activated samples and differences between both groups were found statistically and clinically significant after only 0 minutes. CONCLUSIONS: The non-activated citrated method seems to be reliable and suitable for thrombelastography in non-emergency cases (planned surgical procedures) when we have time to wait 15-30 minutes to get results. In urgent situations a rapid thrombelastography test should be preferred. Although the kaolin-activated method can also be used, results must be interpreted with caution.
Zobrazit více v PubMed
Hartert H. Blutgerinnungsstudien mit der thrombelastographie, einem neuen untersuchungsverfahren. Klin Wochenschr. 1948;26:577–83. doi: 10.1007/BF01697545. PubMed DOI
Scarpelini S, Rhind SG, Nascimento B, Tien H, Shek PN, Peng HT, et al. Normal range values for thromboelastography in healthy adult volunteers. Braz J Med Biol Res. 2009;42(12):1210–7. doi: 10.1590/S0100-879X2009001200015. PubMed DOI
Della Rocca G, Dogareschi T, Cecconet T, Buttera S, Spasiano A, Nadbath P, et al. Coagulation assessment in normal pregnancy: thrombelastography with citrated non activated samples. Minerva Anestesiol. 2012;78(12):1357–64. PubMed
Bowbrick VA, Mikhailidis DP, Stansby G. The use of citrated whole blood in thromboelastography. Anesth Analg. 2000;90(5):1086–8. doi: 10.1097/00000539-200005000-00015. PubMed DOI
Wasowicz M, Srinivas C, Meineri M, Banks B, McCluskey SA, Karkouti K. Technical report: analysis of citrated blood with thromboelastography: comparison with fresh blood samples. Can J Anaesth. 2008;55(5):284–9. doi: 10.1007/BF03017205. PubMed DOI
Wohlauer MV, Moore EE, Harr J, Gonzalez E, Fragoso M, Silliman CC. A standardized technique for performing thromboelastography in rodents. Shock. 2011;36(5):524–6. doi: 10.1097/SHK.0b013e31822dc518. PubMed DOI PMC
Marschner CB, Bjornvad CR, Kristensen AT, Wiinberg B. Thromboelastography results on citrated whole blood from clinically healthy cats depend on modes of activation. Acta Vet Scand. 2010;52:38. doi: 10.1186/1751-0147-52-38. PubMed DOI PMC
White H, Zollinger C, Jones M, Bird R. Can Thromboelastography performed on kaolin-activated citrated samples from critically ill patients provide stable and consistent parameters? Int J Lab Hematol. 2010;32(2):167–73. doi: 10.1111/j.1751-553X.2009.01152.x. PubMed DOI
Polak F, Kolnikova I, Lips M, Parizek A, Blaha J, Stritesky M. New recommendations for thromboelastography reference ranges for pregnant women. Thromb Res. 2011;128(4):e14–7. doi: 10.1016/j.thromres.2011.04.007. PubMed DOI
Hardisty RM, Hutton RA. The kaolin clotting time of platelet-rich plasma: a test of platelet factor-3 availability. Br J Haematol. 1965;11:258–68. doi: 10.1111/j.1365-2141.1965.tb06586.x. PubMed DOI
Durila M. Kaolin activated thromboelastography can result in false positive fibrinolytic trace. Anaesth Intensive Care. 2011;39(4):775–6. PubMed
Camenzind V, Bombeli T, Seifert B, Jamnicki M, Popovic D, Pasch T, et al. Citrate storage affects Thrombelastograph analysis. Anesthesiology. 2000;92(5):1242–9. doi: 10.1097/00000542-200005000-00011. PubMed DOI
Vymazal T, Horacek M, Durpekt R, Hladikova M, Cvachovec K. Is allogeneic blood transfusion a risk factor for sternal dehiscence following cardiac surgery? A prospective observational study. Int Heart J. 2009;50(5):601–7. doi: 10.1536/ihj.50.601. PubMed DOI
Vig S, Chitolie A, Bevan DH, Halliday A, Dormandy J. Thromboelastography: a reliable test? Blood Coagul Fibrinolysis. 2001;12(7):555–61. doi: 10.1097/00001721-200110000-00008. PubMed DOI
Johansson PI, Bochsen L, Andersen S, Viuff D. Investigation of the effect of kaolin and tissue-factor-activated citrated whole blood, on clot-forming variables, as evaluated by thromboelastography. Transfusion. 2008;48(11):2377–83. doi: 10.1111/j.1537-2995.2008.01846.x. PubMed DOI
Gilman EA, Koch CD, Santrach PJ, Schears GJ, Karon BS. Fresh and citrated whole-blood specimens can produce different thromboelastography results in patients on extracorporeal membrane oxygenation. Am J Clin Pathol. 2013;140(2):165–9. doi: 10.1309/AJCPYIQ9JNNSEN4Q. PubMed DOI
Moreland V, Teruya J, Jariwala P. Artifact hyperfibrinolysis in thromboelastography with the use of a heparinase cup. Arch Pathol Lab Med. 2010;134(12):1736. PubMed
Durila M, Kalincik T, Cvachovec K, Filho R. Heparinase-modified thromboelastography can result in a fibrinolytic pattern. Anaesthesia. 2010;65(8):864–5. doi: 10.1111/j.1365-2044.2010.06441.x. PubMed DOI